Incidence of significant adverse events within 24 h following administration of tenecteplase or alteplase for treatment of acute ischemic stroke: A multi-center, single-enterprise, retrospective study

• Sierra M. GreinerCleveland Clinic
• Kaitlin E MarrisonCleveland Clinic
• Frank S RigelskyCleveland Clinic
• Nathan P WirickCleveland Clinic
• Jaclyn M SpergerCleveland Clinic
• Chanda L. MullenCleveland Clinic
• Josef Hadib NissanCleveland Clinic
• John A HromulakCleveland Clinic
• Nathan MohseniCleveland Clinic